Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration autour de Joseph Jankovic - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Clinical Trials as Topic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Clinical Laboratory Techniques < Clinical Trials as Topic < Clinical Trials, Phase II as Topic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000061 (2012) Werner Poewe [Autriche] ; Philipp Mahlknecht ; Joseph Jankovic [États-Unis]Emerging therapies for Parkinson's disease.
000076 (2011) Connie Marras [Canada] ; Michael. Mcdermott ; Ken Marek ; Paula Rochon ; Gary Naglie ; Caroline. Tanner ; Alice Rudolph ; Ira Shoulson ; Anthony. LangPredictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
000123 (2009) Joseph Ferrara [États-Unis] ; Joseph Jankovic [États-Unis]Epidemiology and management of essential tremor in children.
000127 (2009) Bernard Ravina [États-Unis] ; Caroline Tanner ; Diane Dieuliis ; Shirley Eberly ; Emily Flagg ; Wendy. Galpern ; Stanley Fahn ; Christopher. Goetz ; Stephen Grate ; Roger Kurlan ; Anthony. Lang ; Kenneth Marek ; Karl Kieburtz ; David Oakes ; Robin Elliott ; Ira ShoulsonA longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
000169 (2007) James. Sheffield [États-Unis] ; Joseph Jankovic [États-Unis]Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
000202 (2004) Tianhong Pan ; Weidong Le ; Joseph Jankovic [États-Unis]Slowing Parkinson's disease progression: recent dopamine agonist trials.
000219 (2003) Ron Tintner [États-Unis] ; Joseph Jankovic [États-Unis]Dopamine agonists in Parkinson's disease.
000248 (2001) W Le [États-Unis] ; Joseph Jankovic [États-Unis]Are dopamine receptor agonists neuroprotective in Parkinson's disease?
000315 (1988) Joseph Jankovic [États-Unis] ; J. OrmanTetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
000322 (1987) Joseph Jankovic [États-Unis] ; J. OrmanParallel double-blind study of pergolide in Parkinson's disease.
000328 (1985) Joseph Jankovic [États-Unis] ; J. Orman ; B. JanssonPlacebo-controlled study of mesulergine in Parkinson's disease.
000338 (1983) Joseph Jankovic [États-Unis]Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy.
000349 (????) E Tan [États-Unis] ; Joseph Jankovic [États-Unis]Choosing dopamine agonists in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Clinical Trials as Topic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Clinical Trials as Topic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    JankovicV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Clinical Trials as Topic
}}
Wicri

This area was generated with Dilib version V0.6.19.
Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024